| PHUSE EU |
2024 |
Comparison of the Wilcoxon-Signed Rank Test with the Hodges-Lehmann Estimator in SAS, R and StatXact as Part of the PHUSE CAMIS Project |
Agnieszka Tomczyk, Lyn Taylor |
source presentation source |
7 |
| PharmaSUG |
2022 |
Merging Pharmacokinetic (PK) Sample Collection and Dosing Information for PK Analysis based on Study Design and lessons learned |
Durga Kalyani Paturi |
source |
11 |
| PHUSE US |
2022 |
Safety ADaM Automation from Design to Implementation [presentation] |
Chengxin Li, Toshio Kimura |
source video |
18 |
| PHUSE US |
2021 |
Industry Metrics for Extensions of CDISC Terminology [presentation] |
Sergiy Sirichenko |
source video |
36 |
| PHUSE EU |
2019 |
Analysis of crossover studies in patient narratives |
Rebecca Lyzinski |
source presentation source |
6 |
| PHUSE EU |
2019 |
Bioequivalence Testing for Highly Variable Drug Products (HVDPs) |
James R. Johnson |
source presentation source |
9 |
| PharmaSUG |
2019 |
Practical Guide for Creating ADaM Datasets in Cross-over Studies |
Neha Sakhawalkar, Kamleshkumar Patel |
source |
10 |
| PHUSE US |
2019 |
Modeling Safety Pharmacology Study Designs in SEND: An Analysis of a Proof-of-Concept Dataset |
Kevin Snyder |
source presentation source |
5 |
| MWSUG |
2018 |
Avoiding Sinkholes: Common Mistakes During ADaM Data Set Implementation |
Richann J. Watson |
|
15 |
| PharmaSUG |
2018 |
Avoiding Sinkholes: Common Mistakes During ADaM Data Set Implementation |
Richann J. Watson, Karl Miller |
source |
18 |
| WUSS |
2017 |
Avoiding Sinkholes: Common Mistakes During ADaM Data Set Implementation |
Richann J. Watson, Karl Miller |
source |
15 |
| PharmaSUG CN |
2017 |
How to define Treatment Emergent Adverse Event (TEAE) in crossover clinical trials |
Mengya Yin, Wen Tan |
|
6 |
| PharmaSUG |
2017 |
How to define Treatment Emergent Adverse Event (TEAE) in crossover clinical trials |
Mengya Yin, Wen Tan |
source |
6 |
| SESUG |
2016 |
SDTM What? ADaM Who? A Programmer's Introduction to CDISC |
Venita DePuy |
source |
9 |
| PHUSE EU |
2016 |
Cross-over to High Quality Graphics: Using SGRENDER to Enhance Graphics in a Cross-Over Study [presentation] |
Martin Clancy, Simon Clancy, Sue McKendrick, Utpal Sanki |
source presentation presentation source |
1 |
| PharmaSUG |
2016 |
Implementation of ADaM Basic Data Structure for Cross-over Studies |
Songhui Zhu |
source |
10 |
| PharmaSUG |
2016 |
TRTP and TRTA in BDS Application per CDISC ADaM Standards |
Maggie Ci Jiang |
source |
8 |
| SESUG |
2015 |
Multilevel Randomization |
Marina Komaroff, Lois Lynn |
source |
10 |
| PharmaSUG |
2015 |
Implementing Various Baselines for ADaM BDS datasets |
Songhui Zhu |
source |
7 |
| PharmaSUG |
2015 |
Multilevel Randomization |
Marina Komaroff, Lois Lynn |
source |
10 |
| SESUG |
2014 |
SDTM What? ADaM Who? A Programmer's Introduction to CDISC |
Venita DePuy |
source |
9 |
| SGF |
2011 |
Repeated Measures Analysis of Correlated Data with Multiple Responses Using SAS |
Anbuchelvi Jeyabslasingham, Anpalaki J. Ragavan |
source |
10 |
| PharmaSUG |
2010 |
From SAP to ADaM: The Nuts and Bolts |
Nancy Brucken, Paul K. Slagle |
|
9 |
| PharmaSUG |
2010 |
Linear Mixed Models in Clinical Trials using PROC MIXED |
Danyang Bing, Xiaomin He |
|
12 |
| PharmaSUG |
2010 |
Using SAS Proc Power to Perform Model-based Power Analysis for Clinical Pharmacology Studies |
Peng Sun |
|
11 |
| PHUSE EU |
2006 |
Partial Dates; decisions and implications of handling partially missing dates |
Rachel Bowman |
source |
6 |
| PharmaSUG |
2006 |
Estimate Carryover Effect in Clinical Trial Crossover Designs |
David Shen, Zaizai Lu |
|
7 |
| PharmaSUG |
2005 |
Assigning Treatment Group in Cross-over Studies: A Practical Approach |
Charles Ling, Shulin Yuan |
|
3 |
| PharmaSUG |
2004 |
SAS Application in 2x2 Crossover Clinical Trial |
Wuwei Wayne Feng |
|
10 |
| NESUG |
1997 |
Estimation of Direct, Period and Carryover Effects in Crossover Studies |
Mitchell Kotler |
|
7 |
| SUGI |
1997 |
Graphical and Analytical Tools for the Analysis of Two-Period Crossover Clinical Trials |
Jeff A. Sloan, Paul J. Novotny, Charles L. Loprinzi, Suresh Nair |
source |
|
| MWSUG |
1994 |
Use of Macros in Generating Statistical Comparisons for Bioequivalence Reports |
A. David Mundt |
|
9 |
| SUGI |
1992 |
An Interactive SAS/AF System for Assessing Bioequivalence |
Deborah Dukovic |
source |
6 |
| SEUGI |
1991 |
Confidence Intervals for Bioequivalence Studies |
B. Jones, D. J. Nichols, P. Blood |
source |
12 |
| SUGI |
1991 |
A SAS Macro for the Robust Analysis of Repeated Measures Data |
Joe DiGennaro, William J. Huster |
source |
6 |
| SUGI |
1990 |
The Analysis of Data from 2 X 2 Crossover Trials with Baseline Measurements |
Joe DiGennaro, William C. Huster |
source |
6 |